BMS Executive VP of Strategy and Business Development Elizabeth Mily to Step Down

Dec 11, 2023 17:30 CST Updated 17:30

Bristol-Myers Squibb

Biopharmaceutical and Nutritional Product R&D and Sales

On December 8, Bloomberg reported that Elizabeth Mily, Executive Vice President of Strategy and Business Development at Bristol-Myers Squibb (BMS), is set to leave. BMS has confirmed that the company is currently seeking a successor for the position.

Elizabeth Mily has served as Executive Vice President of Corporate Strategy and Business Development at BMS since joining the company in 2020. She is responsible for the company’s strategy and all business development activities, including strategic partnerships, mergers, and acquisitions.

Before joining BMS, Elizabeth Mily served as the director and chair of the global life sciences business within Barclays' global healthcare division. She also held senior executive positions at Thermo Fisher Scientific and Goldman Sachs.

Source: PharmaCube Info

ClickRead the original text Learn More